Though Vaxxinova was officially named and founded in 2010, our predecessors have been in the production animal vaccine and diagnostics business since the 1950s. Vaxxinova can rely on more than 6 decades of expertise in disease prevention for production animals and our products and services are available in more than 60 countries.
Our current technology network comprises production, research & development and diagnostic facilities in 10 countries: Brazil, Chile, Italy, Germany, Japan, Jordan, Norway, Thailand, the USA and the Netherlands. Our location in the Netherlands also serves as our agile headquarters for the Vaxxinova Group.
We aim at providing a full range of both autogenous (where allowed) and licensed vaccines (where registered) combined with high-level diagnostic services, supported by our strong R&D. Our focus is on production animals including poultry, aqua, cattle and swine.
Vaxxinova is part of the family-owned EW Group which is based in Germany and specializes in animal genetics, animal nutrition and animal health. The EW Group operates in over 100 countries and records consistent international growth. Its positive outlook and global orientation have led to an independent and significantly stable position in the market and a steady expansion.